tiprankstipranks
BioMark Diagnostics (TSE:BUX)
:BUX
Canadian Market
BUX
BioMark Diagnostics
RESEARCH TOOLSreports

BioMark Diagnostics (BUX) Cash flow

3 Followers

BioMark Diagnostics Cash Flow

TSE:BUX's free cash flow for Q3 2026 was C$-818.96K. For the 2026 fiscal year, TSE:BUX's free cash flow was decreased by C$-176.94K and operating cash flow was C$-201.54K. See a summary of the company’s cash flow.
Cash Flow
Jun 24Jun 22Jun 21Mar 21Mar 20
Operating Cash Flow
C$ -1.09MC$ -914.42KC$ -1.20MC$ -455.55KC$ -453.79K
Investing Cash Flow
C$ -3.53KC$ -5.30KC$ -59.20KC$ -3.20KC$ -790.00
Financing Cash Flow
C$ 3.42MC$ 609.05KC$ 768.16KC$ 724.63KC$ 1.05M
End Cash Position
C$ 2.48MC$ 72.04KC$ 382.71KC$ 877.68KC$ 611.80K
Free Cash Flow
C$ -1.10MC$ -919.72KC$ -1.26MC$ -455.55KC$ -454.57K
Currency in CAD

BioMark Diagnostics Cash Flow